119 related articles for article (PubMed ID: 36380210)
1. Spleen to non-cancerous liver volume ratio predicts liver cirrhosis in hepatocellular carcinoma patients.
Geng Y; Shao WQ; Lin J
Abdom Radiol (NY); 2023 Feb; 48(2):543-553. PubMed ID: 36380210
[TBL] [Abstract][Full Text] [Related]
2. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma.
Ouyang GX; Zhang YM; Zhu SL; Wang P; Ren Y; Li JH; Liu YK; Chen J; Xiang BD; Li LQ; Liu JY; Zhang ZM
Sci Rep; 2018 Aug; 8(1):13074. PubMed ID: 30166568
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
4. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices.
Wang HQ; Jin KP; Zeng MS; Chen CZ; Rao SX; Ji Y; Fu CX; Sheng RF
Magn Reson Imaging; 2019 Jun; 59():39-45. PubMed ID: 30849483
[TBL] [Abstract][Full Text] [Related]
5. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
[TBL] [Abstract][Full Text] [Related]
6. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction.
Huang TH; Lin MT; Wang JH; Chang KC; Yen YH; Kuo FY; Huang CC; Hsiao CC; Chiu SY; Lu SN; Wang CC; Hu TH
Int J Clin Pract; 2021 Apr; 75(4):e13945. PubMed ID: 33338308
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
9. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
10. Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis.
Wang Z; Liu X; Xu H; Qu L; Zhang D; Gao P
Medicine (Baltimore); 2018 Feb; 97(7):e9843. PubMed ID: 29443746
[TBL] [Abstract][Full Text] [Related]
11. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
Li X; Xu H; Gao P
Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
14. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
16. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
17. Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: Comparison of two-dimensional shear-wave elastography with serum liver fibrosis models.
Chen S; Jiang T
Eur J Radiol; 2020 Dec; 133():109386. PubMed ID: 33160197
[TBL] [Abstract][Full Text] [Related]
18. Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis.
Kim JH; Lee M; Park SW; Kang M; Kim M; Lee SH; Kim TS; Park JM; Choi DH
Medicine (Baltimore); 2018 Nov; 97(48):e13438. PubMed ID: 30508959
[TBL] [Abstract][Full Text] [Related]
19. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.
Song BG; Sinn DH; Chi S; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1447-1452. PubMed ID: 30063482
[TBL] [Abstract][Full Text] [Related]
20. Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
Chin J; Powell LW; Ramm LE; Hartel GF; Olynyk JK; Ramm GA
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1459-1468.e5. PubMed ID: 32745684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
